Arrow International, Inc. Medical Equipment Company Share Analysis
| Publication Date | October 2008 |
|---|---|
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 62 |
| ISBN Number | not applicable |
| Product Code | GMD03382 |
Summary
This report is an essential source for data, analysis and strategic insight into Arrow International, Inc. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines companys business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the companys strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.
Scope
- Revenues for the markets and sub-sectors Arrow International, Inc. operates in by country and region.
- Detailed breakdowns of revenues and market share benchmarked against competitors.
- Profiles of the pipeline of products that the company is developing.
- Critical analysis of the companys strengths, weaknesses opportunities and threats and positioning on the value chain.
- Provides summary analysis of key revenue lines and strategy.
- Details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
- Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.
Reasons to buy
- A single source to fulfill all of your business and competitor intelligence needs
- Research your competitors business structure, strategy and prospects.
- Counter your competitors strengths and target their weaknesses.
- Identify your competitors key revenue streams by market and geography.
- Identify and assess potential corporate and investment opportunities
- Support sales activities by understanding your customers businesses better.
- Identify potential competitor products before they reach market.
- Qualify prospective partners and suppliers.
Content
- 1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 3 Definitions of the Markets/Categories Covered
- 3.1 Cardiovascular Devices
- 3.1.1 Cardiovascular prosthetic device
- 3.1 Cardiovascular Devices
- 4 Company Snapshot
- 4.1 Key Information
- 4.2 Company Overview
- 4.3 Financial Performance
- 4.4 SWOT Snapshot
- 5 Business Description
- 5.1 Business Overview
- 5.2 Cardiac Care
- 5.2.1 Overview
- 5.2.2 Financials
- 5.2.3 Key Strategies
- 5.3 Critical Care
- 5.3.1 Overview
- 5.3.2 Financials
- 5.3.3 Key Strategies
- 5.4 Major Products and Services
- 5.4.1 Overview
- 6 History
- 7 Business Strategy
- 7.1 Mission Statement
- 7.2 Strategy
- 7.3 Corporate Social Responsibility
- 7.3.1 Overview
- 8 Value Chain Analysis
- 8.1 Manufacturing
- 8.1.1 In House Manufacturing
- 8.2 Product Development
- 8.2.1 Regulatory Approvals
- 8.2.2 Clinical Trials
- 8.2.3 Research and Development
- 8.3 Sales and Marketing
- 8.3.1 Partnerships and Alliances
- 8.1 Manufacturing
- 9 SWOT Analysis
- 9.1 Overview
- 9.2 Arrow International, Inc. Strengths
- 9.2.1 Strong sales growth
- 9.2.2 High margins
- 9.3 Arrow International, Inc. Weaknesses
- 9.3.1 Product recall
- 9.3.2 Discontinuation of operations
- 9.3.3 Dependency on health professionals
- 9.4 Arrow International, Inc. Opportunities
- 9.4.1 Acquisitions and strategic alliances
- 9.4.2 Investments in manufacturing
- 9.5 Arrow International, Inc. Threats
- 9.5.1 FDA warning letter
- 9.5.2 Extensive regulation
- 9.5.3 Significant competition and continual technological change
- 10 Competitors
- 11 Arrow International, Inc Medical Equipment Market Share Analysis by Category
- 11.1 Arrow International, Inc., Cardiovascular Devices by Category, Global, Market Share (2007)
- 11.2 Arrow International, Inc., Cardiovascular Devices by Category, APAC, Market Share (2007)
- 11.3 Arrow International, Inc., Cardiovascular Devices by Category, Europe, Market Share (2007)
- 11.4 Arrow International, Inc., Cardiovascular Devices by Category, MEA, Market Share (2007)
- 11.5 Arrow International, Inc., Cardiovascular Devices by Category, North America, Market Share (2007)
- 12 Revenue Analysis
- 12.1 Revenue by Segment
- 12.2 Revenue by Geography
- 13 Financial and Operational Review
- 13.1 Financial Statements
- 13.2 Financial Ratios
- 14 Key Employees
- 15 Key Employee Biographies
- 16 Company Statement
- 17 Locations And Subsidiaries
- 17.1 Head Office
- 17.2 Other Locations & Subsidiaries
- 18 Financial Deals Landscape
- 18.1 Asset Purchase
- 18.1.1 Arrow International Acquires Certain Assets from Kimal
- 18.2 Acquisition
- 18.2.1 Teleflex Acquires Arrow International
- 18.2.2 Arrow International Signs a Distribution Agreement with Esaote
- 18.1 Asset Purchase
- 19 Recent Developments
- 19.1 Financial Announcements
- 19.1.1 Aug 17, 2007: Arrow Declares Quarterly Dividend
- 19.1.2 Jun 28, 2007: Arrow Reports Q3 Fiscal 2007 Results
- 19.1.3 May 14, 2007: Arrow Declares Quarterly Dividend
- 19.1.4 Mar 27, 2007: Arrow Reports Q2 Fiscal 2007 Results
- 19.1.5 Feb 12, 2007: Arrow Declares Quarterly Dividend
- 19.1.6 Jan 04, 2007: Arrow Reports Q1 Fiscal 2007 Results
- 19.2 Other Significant Developments
- 19.2.1 May 31, 2007: Arrow Appoints Interim CEO
- 19.1 Financial Announcements
- 20 Arrow International, Inc. Pipeline Products
- 20.1 CorAide Left Ventricular Assist System
- 20.1.1 Product Overview
- 20.1.2 Product Description
- 20.1.3 Product Status
- 20.1.4 Clinical Trials
- 20.1.5 Product Milestone
- 20.1.6 Product Patent Details
- 20.2 HEMOSONIC Second generation
- 20.2.1 Product Overview
- 20.2.2 Product Description
- 20.2.3 Product Status
- 20.3 NEO PICC Catheter (Modified version)
- 20.3.1 Product Overview
- 20.3.2 Product Description
- 20.3.3 Product Status
- 20.1 CorAide Left Ventricular Assist System
- 21 Appendix
- 21.1 Global Markets Direct Research Methodology
- 21.2 Coverage
- 21.3 Secondary Research
- 21.4 Primary Research
- 21.5 Models
- 21.6 Forecasts
- 21.7 Expert Panels
- 21.8 Market Revenue Chapters
- 21.8.1 Abbreviations
- 21.8.2 Currency Conversions
- 21.9 About Global Markets Direct
- 21.10 Contact Us
- 21.11 Disclaimer
- 1 List of Tables
- Table 1: Arrow International, Inc., Key Facts, 2006
- Table 2: Arrow International, Inc., SWOT Analysis, 2006
- Table 3: Arrow International, Inc. Cardiovascular Devices by Geography, Global, Revenue ($ mn) and Market Share (%), 2007
- Table 4: Arrow International, Inc. Cardiovascular Devices by Geography, APAC, Revenue ($ mn) and Market Share (%), 2007
- Table 5: Arrow International, Inc. Cardiovascular Devices by Geography, Europe, Revenue ($ mn) and Market Share (%), 2007
- Table 6: Arrow International, Inc. Cardiovascular Devices by Geography, MEA, Revenue ($ mn) and Market Share (%), 2007
- Table 7: Arrow International, Inc. Cardiovascular Devices by Geography, North America, Revenue ($ mn) and Market Share (%), 2007
- Table 8: Arrow International, Inc., Revenue by Segment, USD Thousand, 2002-2006
- Table 9: Arrow International, Inc., Revenue by Geography, USD Thousand, 2002-2006
- Table 10: Arrow International, Inc., Financial Statements, USD Thousand, 2002-2006
- Table 11: Arrow International, Inc., Financial Ratios, USD Thousand, 2002-2006
- Table 12: Arrow International, Inc.,Key Employees, 2006
- Table 13: Arrow International, Inc., Subsidiaries
- Table 14: Abbreviations used in the Market Revenue Chapters
- Table 15: Currency Conversion from USD to Local Currency at 2007 Constant Rate
- 1.2 List of Figures
- Figure 1: Arrow International, Inc., Value Chain Analysis
- Figure 2: Arrow International, Inc. Cardiovascular Devices by Category, Global, Share of Market (%), 2007
- Figure 3: Arrow International, Inc. Cardiovascular Devices by Category, APAC, Share of Market (%), 2007
- Figure 4: Arrow International, Inc. Cardiovascular Devices by Category, Europe, Share of Market (%), 2007
- Figure 5: Arrow International, Inc. Cardiovascular Devices by Category, North America, Share of Market (%), 2007
- Figure 6: Global Markets Direct Methodology
About this Product
Delivery Details
PDF:Delivered by email usually within 24 to 48 UK business hours.
Product features / use
| Scope | Expert Insight/Opinion | ![]() |
| Profiles | In-depth Company Insight | ![]() |
| Features | Primary Research Data | ![]() |
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories
















